We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

48 hedge funds and large institutions have $182M invested in Dianthus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 48 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

2.44% more ownership

Funds ownership: 0% → 2.44% (+2.4%)

Holders
48
Holders Change
+48
Holders Change %
–
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
48
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AI
Alphabet Inc
California
+$47.1M
2
EAM
Eventide Asset Management
Massachusetts
+$31.6M
3
CC
Casdin Capital
New York
+$28.7M
4
EC
EcoR1 Capital
California
+$21.7M
5
Fidelity International
Fidelity International
Bermuda
+$11.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Alphabet Inc
California
$45.1M +$47.1M +208,696 New
EAM
2
Eventide Asset Management
Massachusetts
$29.5M +$31.6M +139,881 New
CC
3
Casdin Capital
New York
$27.5M +$28.7M +127,239 New
EC
4
EcoR1 Capital
California
$20.8M +$21.7M +96,131 New
Fidelity International
5
Fidelity International
Bermuda
$11.2M +$11.7M +51,655 New
OM
6
Opaleye Management
Massachusetts
$7.42M +$7.76M +34,375 New
Principal Financial Group
7
Principal Financial Group
Iowa
$5.53M +$5.78M +25,615 New
LCM
8
Laurion Capital Management
New York
$4.72M +$4.94M +21,875 New
HMC
9
Harvard Management Company
Massachusetts
$4.49M +$4.69M +20,788 New
VOYA Investment Management
10
VOYA Investment Management
Georgia
$3.39M +$3.54M +15,684 New
AG
11
Artal Group
Luxembourg
$2.7M +$2.82M +12,500 New
ACP
12
Acuta Capital Partners
California
$2.29M +$2.4M +10,625 New
NC
13
Nexthera Capital
New York
$2.02M +$2.12M +9,375 New
MIM
14
Monashee Investment Management
Massachusetts
$1.86M – – –
Millennium Management
15
Millennium Management
New York
$1.51M +$1.58M +6,984 New
BlackRock
16
BlackRock
New York
$1.35M +$1.41M +6,250 New
Citadel Advisors
17
Citadel Advisors
Florida
$1.17M +$1.22M +5,425 New
SM
18
Sabby Management
Florida
$1.02M +$1.07M +4,738 New
Goldman Sachs
19
Goldman Sachs
New York
$1.02M +$1.07M +4,719 New
Norges Bank
20
Norges Bank
Norway
$1.01M +$1.06M +4,688 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.01M +$1.06M +4,688 New
Alkeon Capital Management
22
Alkeon Capital Management
New York
$918K +$959K +4,250 New
UOC
23
UBS O'Connor
Illinois
$810K +$846K +3,750 New
PIM
24
Platinum Investment Management
Australia
$675K +$705K +3,125 New
DIM
25
DC Investments Management
Virginia
$558K +$583K +2,583 New
1
2

DNTH Hedge Fund Activity: Q2 2018 in Review

48 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q2 2018, worth a combined $182M.

Buyers outnumbered sellers: 48 funds opened new DNTH positions and 0 closed out — a net gain of 48 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Alphabet Inc, opening a new position worth an estimated $47.1M.

  • 48 institutional investors held Dianthus Therapeutics (DNTH) as of Q2 2018, up from 0 in Q1 2018.
  • Funds reported $182M of Dianthus Therapeutics stock for Q2 2018.
  • 48 funds opened new Dianthus Therapeutics positions in Q2 2018 and 0 closed out, a net change of +48 holders.
  • The largest Dianthus Therapeutics buyer in Q2 2018 was Alphabet Inc, an estimated $47.1M added.

Based on aggregated 13F filings for Q2 2018.